Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 15 Health Care Angel Investors in Belgium in February 2025

Last updated: Feb 2025 A list of 15 angel investors that invest in Health care startups based in Belgium. We rank investors based on the number of investments they made in Health care companies from Belgium. We update this investor list every month.

Top 15 Health Care Angel Investors in Belgium in February 2025

Investor	Health Care Belgium investments
Pierre Rigaux	4
Annie Vereecken	4
Pierre Drion	3
Yves Beudin	1
Herman Verrelst	1
Eric Janvier	1
Griet Nuytinck	1
Manuel Thurner	1
David Prior	1
Eyal Gura	1
Evren Ucok	1
Jean Dessain	1
Virginie Saverys	1
Eduardo Ronzano	1
Kenneth Buckfire	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Pierre Rigaux

Investment focus

Sports, Medical Device
Seed, Pre-Seed, Convertible Note
Belgium

Portfolio highlights

MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.

Annie Vereecken

Investment focus

Biotechnology, Medical, Hospital
Seed, Series A, Funding Round
Belgium

Portfolio highlights

Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
Sensolus — Introducing our smart, industrial-grade tracking solution. With battery life of up to ten years, and no additional infrastructure needed.
Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).

Pierre Drion - CEO @ Petercam

Investment focus

Biotechnology, Health Care, Life Science
Series A, Series B, Funding Round
Belgium

Portfolio highlights

A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.

Yves Beudin

Investment focus

Medical, Health Care, Biotechnology
Angel
Belgium

Portfolio highlights

OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.

Herman Verrelst

Investment focus

Medical, Hospital, Biotechnology
Series A
Belgium

Portfolio highlights

UgenTec — FastFinder is intelligent software that automates sample workflow, ensures your assays are analyzed consistently and cuts data analysis time in half.

Eric Janvier

Investment focus

Medical, Health Care
Series A
Belgium

Portfolio highlights

Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.

Griet Nuytinck is founder of Anacura.

Investment focus

Medical, Life Science, Biotechnology
Seed
Belgium

Portfolio highlights

4Tissue — Shaping the Future of Regenerative Medicine

Manuel Thurner is the Co-Founder and Co-CEO at Kaia Health. He attended the Technical University of Munich, Massachusetts Institute of Technology, and Center for Digital Technology and Management, CDTM.

Investment focus

iOS, Software, Navigation
Pre-Seed, Seed
Germany, Belgium

Portfolio highlights

OCELL — Building the Operating System of Sustainable Forestry
AYES — AYES provides the leading AI service to create accessible mobility for blind and visually impaired people.
Kranus Health — Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.

David Prior is the former chair of the UK's National Health Service.

Investment focus

Health Care, Medical, Software
Seed
Belgium, United Kingdom

Portfolio highlights

TORTUS AI — Innovative medical AI which revolutionises the healthcare industry by enhancing clinical operations and patient care. Book a free demo today.
Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.

Eyal Gura is the Board Member of Imagene AI. He previously worked at Zebra Medical Vision Ltd as a Co-Founder, President and Chairman of the Board. Eyal Gura attended Reichman University (IDC Herzliya).

Investment focus

Software, Mobile, Artificial Intelligence
Series A, Seed, Series B
United States, Israel, Belgium

Portfolio highlights

Theator — Discover the world's first surgical intelligence platform from theator. Continually perfect your craft with AI & computer vision technology.
Taranis — Taranis offers cutting-edge crop & farm management software for precision agriculture. Increase efficiency and yield. Learn more now.
Imagene AI — Imagene is a pioneering company in AI-powered Oncology Intelligence dedicated to decoding cancer using biopsy images.

Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform. He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.

Investment focus

Medical, Health Care, Life Science
Series A
Turkey, Belgium

Portfolio highlights

idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.

Jean Dessain - Non Executive Director @ OneLIFE

Investment focus

Medical, Health Care, Biotechnology
Angel
Belgium

Portfolio highlights

OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.

Virginie Saverys is a entrepreneur.

Investment focus

Medical, Life Science, Biotechnology
Seed
Belgium

Portfolio highlights

4Tissue — Shaping the Future of Regenerative Medicine

Eduardo Ronzano is the Co-Founder and CEO of Kolet. He previously worked at The Bradery as a Pre-Seed Investor. Eduardo Ronzano attended ESCP Business School.

Investment focus

Software, SaaS, E-Commerce
Seed, Pre-Seed, Angel
France, United States, United Kingdom

Portfolio highlights

Screeb — Make products your users will love by using Screeb, the all-in-one tool for Product Discovery. Product analytics, user recruitment, and more!
Frak Labs — Manage your unified web identity, earn rewards, and interact seamlessly with partner websites using our passkey-first blockchain smart wallet.
Poolside — The best code you never wrote.

Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.

Investment focus

Medical, Health Care, Life Science
Series A
Belgium

Portfolio highlights

Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.

Investors by industry

Artificial intelligence